In 2004 a 32 year old man died from testicular cancer after he refused surgery.
Rife machine skin cancer.
Ultimate guide to rife machine.
Cancer could not be found after my father used the spooky2 rife machine for 3 months.
In the stomach small intestine and large intestine.
Spooky2 success story hannah.
A rife machine produces low energy electromagnetic waves that are similar to radio waves.
These waves are similar to radio waves.
This device invented nearly a century ago.
He decided to avoid chemo radiations and went the natural route.
Follow us on facebook.
If you have cancer you may be willing to try anything that you think could cure your disease one treatment you may have heard of is a rife machine.
Rife machines use electromagnetic frequency.
Rife machines produce low electromagnetic energy waves.
Some claim that the machine destroys cancer cells by tuning into the electrical.
My father was diagnosed with non hodgkin lymphoma.
He performed thousands of experiments each proving that cancer has a viral cause and that damaging this virus usually resulted in a cure.
A rife machine uses the principles of royal rife a brilliant scientist who lived during the last century he discovered that micro organisms can be destroyed using frequencies.
Once he began treating cancer patients i had the brochure taped to the wall in front of my desk he says it was a holy spirit moment.
Proponents claim that using the device on the body can cure cancer and treat other conditions such as hiv.
Spooky 2 gives you not one but many rife machines in one package with plasma contact remote pemf cold laser audio and more.
The rife machine is a device that was invented nearly a century ago.
Kevin conner became fascinated with rife technology when he was in school.
The cancer was spread throughout his entire digestive tract.
In 1997 a man died four months after he started using a rife machine instead of chemotherapy to treat his cancer.
Supporters of the treatment claim that the rife machine can treat different conditions including cancer.
